Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Silvia Rizzati 1 Article
Coexistence of VHL Disease and CPT2 Deficiency: A Case Report
Alfonso Massimiliano Ferrara, Monica Sciacco, Stefania Zovato, Silvia Rizzati, Irene Colombo, Francesca Boaretto, Maurizio Moggio, Giuseppe Opocher
Cancer Res Treat. 2016;48(4):1438-1442.   Published online March 25, 2016
DOI: https://doi.org/10.4143/crt.2015.450
AbstractAbstract PDFPubReaderePub
von Hippel-Lindau (VHL) disease is an inherited syndrome manifesting with benign and malignant tumors. Deficiency of carnitine palmitoyltransferase type II (CPT2) is a disorder of lipid metabolism that, in the muscle form, manifests with recurrent attacks of myalgias often associated with myoglobinuria. Rhabdomyolytic episodes may be complicated by life-threatening events, including acute renal failure (ARF). We report on a male patient who was tested, at 10 years of age, for VHL disease because of family history of VHL. He was diagnosed with VHL but without VHL-related manifestation at the time of diagnosis. During childhood, the patient was hospitalized several times for diffuse muscular pain, muscle weakness, and dark urine. These recurrent attacks of rhabdomyolysis were never accompanied by ARF. The patient was found to be homozygous for the mutation p.S113L of the CPT2 gene. To the best of our knowledge, this is the first report of the coexistence of VHL disease and CPT2 deficiency in the same individual. Based on findings from animal models, the case illustrates that mutations in the VHL gene might protect against renal damage caused by CPT2 gene mutations.

Citations

Citations to this article as recorded by  
  • A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives
    Zhongyu Han, Yuanke Luo, Haoran Chen, Guochen Zhang, Luling You, Meiqi Zhang, Yumeng Lin, Lan Yuan, Shiyi Zhou
    Kidney Diseases.2024; 10(3): 224.     CrossRef
  • Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions
    Kenan Zhang, Wuping Yang, Kaifang Ma, Jianhui Qiu, Lei Li, Yawei Xu, Zedan Zhang, Chaojian Yu, Jingcheng Zhou, Yanqing Gong, Lin Cai, Kan Gong
    Journal of Medical Genetics.2023; 60(5): 477.     CrossRef
  • Idiopathic interstitial pneumonia in a patient with von Hippel–Lindau syndrome: a first case
    Letizia Corinna Morlacchi, Umberto Zanini, Andrea Gramegna, Paola Faverio, Francesco Blasi, Fabrizio Luppi
    ERJ Open Research.2023; 9(6): 00504-2023.     CrossRef
  • The Cross‐Link between Ferroptosis and Kidney Diseases
    Jingyu Wang, Yi Liu, Yaqing Wang, Li Sun, Ana Cipak Gasparovic
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Prioritization of differentially expressed genes through integrating public expression data
    W. Xu, S. Li, Z. Zhang, J. Hu, Y. Zhao
    Animal Genetics.2019; 50(6): 726.     CrossRef
  • 13,774 View
  • 170 Download
  • 6 Web of Science
  • 5 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP